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Positron Annihilation Lifetime Spectroscopy (PALS) is a technique
based on the analysis of the lifetime of positronium emitted from implanted
or delivered positronium donors. This technique employs the lifetime and
intensity dependence on the structure of analyzed material. Due to this spe-
cific features, PALS might be used in further research protocols and clinical
studies for cancer diagnostic purposes. This article reports the progress in
the study design, main objectives of the study, protocols of measurements
and data analysis and further perspective of this study. The main goal of
this work was to show the effectiveness of this method and progress in its
development. For this purpose, colorectal cancer was examined.
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1. Introduction
Nowadays cancer is a major cause of mortality and it affects people all
around the world. Among many, the colorectal tumor is the third and second
most common source of cancer among men and women, respectively [1].
Understanding of cancer biology is critical to develop a rationally designed
therapy and to offer preventive options [1]. One of the biggest challenges of
diagnostic medicine is early recognition of the disease and precise localization
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of its cause [2, 3]. Combining the J-PET tomography [4–8] (that enables
detection of cancer at the early stage of its development) with Positron
Annihilation Lifetime Spectroscopy (which can test structural changes in
biological polymeric systems), it may be possible to tell more about the
structure of the cancer without a biopsy [2, 8, 9]. In this article, the basics
of these measurements are explained. This research will allow to establish
the precision of J-PET tomograph for PALS measurements [6]. Samples of
both colon normal and cancer tissues are studied ex vivo by means of the
PALS detectors.
2. Method
The main objective of this study is the investigation of differences in
life-times of ortho-positronium (o-Ps) formed in samples obtained from colon
cancer and normal tissues. We assume that positron emitted from 22Na ther-
malizes in cancer or normal tissue and forms a positronium whose lifetime
is different and depends on tissue structure and metabolism. The source
of positrons is a β+ radioactive isotope which decays to an excited nucleus
which, subsequently, deexcites via emission of the gamma quantum. For
example, 22Na isotope after emission of a positron transforms into the ex-
cited 22Ne nucleus which then emits almost immediately (on the average in
about 3 ps) γ quantum with the energy of 1274 keV [6, 10]. The positron
emitted into the sample thermalizes and forms a positronium atom or an-
nihilates directly with one of the electrons from the sample. Positronium,
depending on the spin state, can annihilate with emission of two or more
γ quanta. Para-positronium (p-Ps) state (S = 0) annihilates with emis-
sion of two γ quanta with mean lifetime of 0.125 ns in vacuum, while o-Ps
(S = 1) annihilates with emission of three γ quanta with a mean lifetime of
142 ns in vacuum [11]. However, due to a processes such as, for example,
pick-off or ortho–para conversion, there is a chance that o-Ps annihilates
with emission of two γ quanta and a significantly lower mean lifetime [11].
The latter depends on the size of the space between molecules, so-called
“free volumes”. The smaller a free volume is, the lower is the mean lifetime
of o-Ps [12–14]. Changes of the o-Ps mean lifetime reflect changes in the
material structure and, therefore, they may be connected to the morphology
of cells of the living organisms [2, 5, 9, 10, 15]. Taking into consideration
that o-Ps lifetime modifications result from electromagnetic interactions of
o-Ps with water molecules and other cell-building compounds as proteins or
lipids, properties of positronium, for example, the lifetime, may be different
in cancerous and normal tissues due to their different molecular structure.
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3. Colon cancer
Carcinogenesis of colorectal cancer is not completely understood. The
reason of this process is the formation of multiple cytogenetic and epigenetic
changes as a result of long exposure to environmental and innate cancer risk
factors that disrupt cellular homeostasis [16]. These environmental factors
may be, for example: wrong diet, smoking or diabetes. The gene responsi-
ble for colorectal cancer is the adenomatous polyposis coli (APC). Germ-line
mutations in the APC gene result in familial adenomatous polyposis (FAP),
one of the principal hereditary predispositions to colorectal cancer [3]. Colon
cancer is one of the most common cancer types in the world. The risk of
geting colorectal cancer rises dramatically with age, by the age of 70, ap-
proximately half of the modern people will have developed adenoma [1, 3].
At least four changes in genome sequences need to take place in order to
cause the colorectal cancer evolution. The main targets of the changes are:
KRAS (oncogene), APC, SMAD4 and TP53 (tumour suppressor genes) [3].
Macroscopically, tumors have various morphological forms. Ascending colon
tumors can occur with an exophytic/fungal growth pattern with the forma-
tion of a large polypous mass, often with ulceration. In the descending
colon, tumors tend to have a flat, annular growth leading to narrowing of
the intestinal lumen [3]. Colonoscopy is the basic examination enabling the
diagnosis of colorectal cancer [1]. This method is one of the endoscopic ex-
aminations that could provide the visual image thanks to a CCD camera or
a fiber optic camera on a flexible tube passed through the anus. About 1 out
of 200 people who undergo colonoscopy experience a serious complication,
for example, gastrointestinal perforation or bleeding [17]. In this case, the
scientists from the Institute of Physics of the Jagiellonian University devel-
oped another method of diagnostic colon cancer. Combining PET scanner
with PALS technique [6] may improve a colon cancer diagnostic with less
complications, as it will be an non-invasive examination.
4. Measurements
Samples were delivered from the 2nd Department of General Surgery,
Jagiellonian University Medical College in Kraków. Both normal and can-
cerous tissues originated from the large intestine. For the studies, all patients
with colrectal cancer were accepted, the only excluding criteria were: the
size of tumor (if smaller than ∼ 1 cm3) and positive tests for HIV, hepatitis B
and C. Reaserch has been conducted based on the agreement of the Bioethi-
cal Committee of the Jagiellonian University No. 1072.6120.13.2019. During
the surgery, half of the tumor was allocated for histopathology examination
while the other part was transferred to the Faculty of Physic, Astronomy
and Applied Computer Science for PALS measurements. The tissue samples
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were transported in the thermally-isolated container, to maintain a stable
temperature through all procedures. Epidemiological and clinical data re-
garding risk factors, treatments and patient conditions and co-morbidities
were collected. Additionally, data related to cancer stage and progression
were collected and confirmed by histopathological examinations. Patients
with radio- and chemotherapy prior to surgery were included in the study
to test the influence of different treatments on o-Ps lifetime.
Fig. 1. Examples of normal (left) and cancerous (right) samples of colon tissues
studied with PALS.
Both, the colon cancer and normal tissue samples were placed in an alu-
minium chamber. THe 22Na source (1MBq) was used as a positron emitter
placed in between two parts of the same tissue. The chamber was inserted
between two BaF2 scintillators as shown in Fig. 2. The two detectors were
red out by the DRS4 digitizer.
Fig. 2. Photograph showing the experimental setup used in performed PALS mea-
surements. Two scintillator detectors with BaF2 crystals were used. The sample
was encapsulated together with an 22Na source sealed in 0.6 µm thick Kapton foil
in the aluminum chamber seen in the picture.
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As a result of the measurements, we have obtained for each sample a PAL
spectrum which was then used to estimate the mean lifetime in the studied
tissues. The analysis was performed by the PALS Avalanche software [18, 19].
In Fig. 3, one can see exemplary PAL spectrum with fitted model. Each
component is related to the different type of positron annihilation.
Fig. 3. (Color online) Exemplary PAL spectrum for a cancer sample from patient
No. 1. Red curve indicates model fitted to the positron lifetime distribution. It
consists of a contribution originated from the detection setup itself (due to its
time resolution) constant background (purple) and a set of exponential functions
originating from positron annihilation: o-Ps decay (green, with lifetime 1.988 ns),
free positron annihilation (blue, with lifetime 0.416), annihilation in the source
itself (olive green, with lifetime 0.374) and p-Ps decay (light blue, with lifetime
0.133).
5. Conclusions
The mean o-Ps lifetime can be successfully estimated for every sample,
both normal and cancer. A detailed procedure for sample preparation and
measurement was developed and tested for performing repeatable measure-
ments. Influence of aforementioned risk factors on the structural alterations
was tested in correlation with o-Ps mean lifetime. The most challenging
aspect of conducted research is to determine how the macroscopic factors
mentioned above affect changes at the atomic level. The main difficulty is
to find a diagnostic relevance pattern between the o-Ps lifetime and differ-
ent biological processes occurring within cells and tissues which changes not
only its structure but also cellular signaling and activity.
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